Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med. 2008;38:771–85.

Article  CAS  PubMed  Google Scholar 

Bech P, Kastrup M, Rafaelsen OJ. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl. 1986;326:1–37.

CAS  PubMed  Google Scholar 

Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125:279–84.

Article  CAS  PubMed  Google Scholar 

Bora E. Neurocognitive features in clinical subgroups of bipolar disorder: a meta-analysis. J Affect Disord. 2018;229:125–34.

Article  PubMed  Google Scholar 

Bora E, Ozerdem A. Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia. Psychol Med. 2017;47:2753–66.

Article  CAS  PubMed  Google Scholar 

Borkowski JG, Benton AL, Spreen O. Words fluency and brain damage. Neuropsychologia. 1967;5:135–40.

Article  Google Scholar 

Crawford JR, Besson JA, Parker DM, Sutherland KM, Keen PL. Estimation of premorbid intellectual status in depression. Br J Clin Psychol. 1987;26(Pt 4):313–4.

Article  CAS  PubMed  Google Scholar 

Cullen B, Smith DJ, Deary IJ, Pell JP, Keyes KM, Evans JJ. Understanding cognitive impairment in mood disorders: mediation analyses in the UK Biobank cohort. Br J Psychiatry. 2019;17:41.

Google Scholar 

da Silva J, Goncalves-Pereira M, Xavier M, Mukaetova-Ladinska EB. Affective disorders and risk of developing dementia: systematic review. Br J Psychiatry. 2013;202:177–86.

Article  PubMed  Google Scholar 

Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. 2nd ed. USA: Wiley; 2011.

Book  Google Scholar 

Futtrup J, Margolinsky R, Benros ME, Moos T, Routhe LJ, Rungby J, Krogh J. Blood-brain barrier pathology in patients with severe mental disorders: a systematic review and meta-analysis of biomarkers in case–control studies. Brain Behav Immun Health. 2020;6: 100102.

Article  PubMed  PubMed Central  Google Scholar 

Jensen JH, Knorr U, Vinberg M, Kessing LV, Miskowiak KW. Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: associations with functional abilities. J Affect Disord. 2016;205:378–86.

Article  PubMed  Google Scholar 

Jimenez-Lopez E, Sanchez-Morla EM, Lopez-Villarreal A, Aparicio AI, Martinez-Vizcaino V, Vieta E, Rodriguez-Jimenez R, Santos JL. Neurocognition and functional outcome in patients with psychotic, non-psychotic bipolar I disorder, and schizophrenia, a five-year follow-up. Eur Psychiatry. 2019;56:60–8.

Article  PubMed  Google Scholar 

Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J Neurol Neurosurg Psychiatry. 2004;75:1662–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kessing LV, Andersen PK. Evidence for clinical progression of unipolar and bipolar disorders. Acta Psychiatr Scand. 2017;135:51–64.

Article  CAS  PubMed  Google Scholar 

Kjaerstad HL, Mistarz N, Coello K, Stanislaus S, Melbye SA, Harmer CJ, Vinberg M, Miskowiak K, Kessing LV. Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives. Psychol Med. 2019;50:1808–19.

Article  PubMed  Google Scholar 

Knorr U, Simonsen AH, Roos P, Weimann A, Henriksen T, Christensen EM, Vinberg M, Mikkelsen RL, Kirkegaard T, Jensen RN, Akhoj M, Forman J, Poulsen HE, Hasselbalch SG, Kessing LV. Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case–control study. Transl Psychiatry. 2019;9:325.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Knorr U, Miskowiak K, Akhøj M, Vinberg M, Forman J, Kessing LV. The impact of the trajectory of bipolar disorder on global cognitive function: a one-year clinical prospective case–control study. J Affect Disord. 2020;278:189–98.

Article  PubMed  Google Scholar 

Knorr U, Simonsen AH, Jensen CS, Zetterberg H, Blennow K, Akhøj M, Forman J, Hasselbalch SG, Kessing LV. Alzheimer’s disease related biomarkers in bipolar disorder—a longitudinal one-year case–control study. J Affect Disord. 2022;297:623–33.

Article  CAS  PubMed  Google Scholar 

Kylkilahti TM, Berends E, Ramos M, Shanbhag NC, Töger J, Markenroth Bloch K, Lundgaard I. Achieving brain clearance and preventing neurodegenerative diseases—a glymphatic perspective. J Cereb Blood Flow Metab. 2021;41:2137–49.

Article  PubMed  PubMed Central  Google Scholar 

Lleo A, Alcolea D, Martinez-Lage P, Scheltens P, Parnetti L, Poirier J, Simonsen AH, Verbeek MM, Rosa-Neto P, Slot RER, Tainta M, Izaguirre A, Reijs BLR, Farotti L, Tsolaki M, Vandenbergue R, Freund-Levi Y, Verhey FRJ, Clarimon J, Fortea J, Frolich L, Santana I, Molinuevo JL, Lehmann S, Visser PJ, Teunissen CE, Zetterberg H, Blennow K. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer’s disease continuum in the BIOMARKAPD study. Alzheimer’s Dementia. 2019;15:742–53.

Article  PubMed  Google Scholar 

Lyketsos CG. Treatment development for Alzheimer’s disease: how are we doing? Adv Exp Med Biol. 2020;1195:19.

Article  CAS  PubMed  Google Scholar 

Mavroudis IA, Petridis F, Chatzikonstantinou S, Kazis D. A meta-analysis on CSF neurogranin levels for the diagnosis of Alzheimer’s disease and mild cognitive impairment. Aging Clin Exp Res. 2020;32:1639–46.

Article  PubMed  Google Scholar 

McIntyre RS, Berk M, Brietzke E, Goldstein BI, López-Jaramillo C, Kessing LV, Malhi GS, Nierenberg AA, Rosenblat JD, Majeed A, Vieta E, Vinberg M, Young AH, Mansur RB. Bipolar disorders. Lancet. 2020;396:1841–56.

Article  CAS  PubMed  Google Scholar 

Merluzzi AP, Vogt NM, Norton D, Jonaitis E, Clark LR, Carlsson CM, Johnson SC, Asthana S, Blennow K, Zetterberg H, Bendlin BB. Differential effects of neurodegeneration biomarkers on subclinical cognitive decline. Alzheimer’s Dementia (new York, n.y). 2019;5:129–38.

Article  PubMed  Google Scholar 

Molano JRV, Roe CM, Ju YS. The interaction of sleep and amyloid deposition on cognitive performance. J Sleep Res. 2017;26:288–92.

Article  PubMed  Google Scholar 

Naserkhaki R, Zamanzadeh S, Baharvand H, Nabavi SM, Pakdaman H, Shahbazi S, Vosough M, Ghaedi G, Barzegar A, Mirtorabi D, Hedayatshodeh M, Ehsani E, Falahati M, Hajipour MJ, Shahpasand K. cis pT231-Tau drives neurodegeneration in bipolar disorder. ACS Chem Neurosci. 2019;10:1214–21.

Article  CAS  PubMed  Google Scholar 

Obrocki P, Khatun A, Ness D, Senkevich K, Hanrieder J, Capraro F, Mattsson N, Andreasson U, Portelius E, Ashton NJ, Blennow K, Scholl M, Paterson RW, Schott JM, Zetterberg H. Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg. Alzheimers Res Ther. 2020;12:20.

Article  PubMed  PubMed Central  Google Scholar 

Ottesen NM, Meluken I, Frikke-Schmidt R, Plomgaard P, Scheike T, Kessing LV, Miskowiak K, Vinberg M. S100B and brain derived neurotrophic factor in monozygotic twins with, at risk of and without affective disorders. J Affect Disord. 2020;274:726–32.

Article  CAS  PubMed  Google Scholar 

Pandolfo G, Iannuzzo F, Genovese G, Bruno A, Pioggia G, Baldari S, Gangemi S. Mental illness and amyloid: a scoping review of scientific evidence over the Last 10 Years (2011 to 2021). Brain Sci. 2021;11:1352.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pech J, Akhøj M, Forman J, Kessing LV, Knorr U. The impact of a new affective episode on psychosocial functioning, quality of life and perceived stress in newly diagnosed patients with bipolar disorder: a prospective one-year case–control study. J Affect Disord. 2020;277:486–94.

Article  PubMed  Google Scholar 

Pereira JB, Janelidze S, Ossenkoppele R, Kvartsberg H, Brinkmalm A, Mattsson-Carlgren N, Stomrud E, Smith R, Zetterberg H, Blennow K, Hansson O. Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease. Brain. 2021;144:310–24.

Article  PubMed  Google Scholar 

Purdon SE. Screen for cognitive impairment in psychiatry: administration and psychometric properties. Alberta, Canada: PNL Inc; 2005.

Google Scholar 

Rasmussen MK, Mestre H, Nedergaard M. The glymphatic pathway in neurological disorders. Lancet Neurol. 2018;17:1016–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Rheenen, T.E., Lewandowski, K.E., Bauer, I.E., Kapczinski, F., Miskowiak, K., Burdick, K.E., Balanza-Martinez, V., 2019. Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence. Bipolar disorders.

Richmond-Rakerd LS, D’Souza S, Milne BJ, Caspi A, Moffitt TE. Longitudinal associations of mental disorders with dementia: 30-year analysis of 1.7 million New Zealand Citizens. JAMA Psychiat. 2022;79:333–40.

Article  Google Scholar 

Rieck JR, Rodrigue KM, Kennedy KM, Devous MD Sr, Park DC. The effect of beta-amyloid on face processing in young and old adults: a multivariate analysis of the BOLD signal. Hum Brain Mapp. 2015;36:2514–26.

Article  PubMed  PubMed Central  Google Scholar 

Rolstad S, Jakobsson J, Sellgren C, Ekman CJ, Blennow K, Zetterberg H, Palsson E, Landen M. Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls. PLoS ONE. 2015;10: e0127100.

Article  PubMed  PubMed Central